Canadian data is current through March 2018. All of the data comes from Health Canada, except for the categories Manufacturer Parent Company and Product Classification.
The Parent Company and the Product Classification were added by ICIJ.
The parent company information is based on 2017 public records. The device classification information comes from FDA’s Product Classification by Review Panel, based on matches of recall data from the U.S. and Canada.
데이터 추가 비고
원인
May be hazardous to health: the cd8 pe reagent is contaminated with cd4 fitc. cd4 cells will be expressed along the fitc axis. any marker that is stained for on the fitc axis will contain this incorrectly stained cd4 population. with subsequent downgating the results will appear as if the cd4 population is not present. this could result in the unnecessary intensification of therapy for patients already known to have reductions in their cd4 levels.